What Public Home Health & Home Care Company Valuations Mean for Private Sellers

Every trading day, the market puts a precise price on a handful of publicly traded home-based care companies. Most home care owners never look at those numbers. They should — because those public valuations quietly set the benchmark that private buyers anchor to when they value your agency.

This guide explains how to read public comparables (“comps”), why your agency almost certainly trades at a discount to them, how public-market sentiment flows into private deal appetite, and what actually closes the gap. It is a methodology, not a stock tip — the specific multiples move constantly, so the durable value is in knowing how to think about them.

---

The Public Companies That Set the Benchmark

A relatively small group of public companies represents the investable, home-based care universe. The roster shifts as consolidation takes names private, but the segment is usually represented by companies such as:

• Addus HomeCare (ADUS) — personal care and home care
• The Pennant Group (PNTG) — home health, hospice, and senior living
• Enhabit (EHAB) — home health and hospice
• Aveanna Healthcare (AVAH) — pediatric home health and private duty nursing
• Option Care Health (OPCH) — home and alternate-site infusion
• BrightSpring Health Services (BTSG) — home and community health and pharmacy
• Chemed (CHE) — parent of VITAS, a large hospice operator

The list itself tells a story. Several of the largest pure-play home health platforms have been acquired outright by strategic buyers in recent years, taking them private and shrinking the public roster — a consolidation signal that, by itself, set headline benchmarks for the whole sector.

---

What “Comps” Actually Measure

The most common comparable metric is enterprise value to EBITDA (EV/EBITDA). Enterprise value is the company’s equity value plus net debt; dividing by EBITDA produces the multiple the market is paying for each dollar of earnings.

Because public companies report audited financials and trade daily, their EV/EBITDA multiples are transparent and current. That transparency is exactly why buyers and advisors keep them on the desk as one reference point — alongside precedent private transactions, which are often the more relevant comparable for a lower-middle-market agency.

For how EBITDA itself is built and adjusted before any multiple is applied, see home care EBITDA add-backs and our complete valuation formula.

---

Why Your Agency Trades at a Discount

Here is the part that surprises owners: a private agency almost always trades below the public platforms — frequently by a wide margin — even when it is exceptionally well run. The discount is structural, not a judgment on your operations:

• Size. Smaller absolute EBITDA carries more risk per dollar; buyers pay less for it.
• Liquidity. Public shares can be sold instantly; a private agency cannot. Buyers demand a discount for illiquidity.
• Concentration. Reliance on a few payers, referral sources, or large clients raises risk.
• Key-person dependence. When the business runs through the owner, the buyer is purchasing a transition risk.
• Management depth. Public companies have layered infrastructure; many private agencies do not.

This is why the headline number you read about a public company — or a mega-platform acquisition — is the ceiling of the conversation, not your starting point. The gap between that ceiling and your value is the sum of the discounts above.

As a directional frame only: public home health and hospice platforms have historically traded across a broad band of high-single-digit to mid-teens EV/EBITDA depending on the segment and the cycle, while private lower-middle-market home care agencies typically transact at meaningfully lower multiples that scale upward with size and quality. Treat those as illustrative ranges to be confirmed at the time of a process — not as a current quote. Our 2026 EBITDA multiples benchmark report covers the private side in detail.

---

How Public Sentiment Reaches Your Deal

Public multiples do not set your price directly, but they shape the appetite and discipline of the buyers who do — and the relationship operates with a lag:

• When public multiples compress, financial sponsors become more price-disciplined, and strategic acquirers who pay partly in stock find their “currency” worth less. Both cool private bidding.
• When public multiples expand, capital flows into the sector chasing growth, and private multiples tend to follow upward.

This is also why the type of buyer you attract matters so much in different market conditions — see strategic buyer vs. private equity. A public-market downturn can shift leverage from sellers to buyers within a quarter or two, which is one reason timing and process design matter. Our 2026 home care M&A market update tracks where the cycle sits now.

---

What Closes the Gap

The good news: the discount is not fixed. The factors that move a private agency toward public-platform valuations are the same ones that drive any premium:

• Scale — larger EBITDA earns a higher multiple, full stop.
• Diversification — across payers, geographies, and referral sources.
• Management depth — a business that runs without the owner.
• Clean financials — audited or audit-ready, with defensible add-backs.
• A credible growth story — de novo expansion, service-line extension, or tuck-in potential.

Each of these directly answers one of the discount factors above. Building them before you go to market is how owners convert a “small private discount” into a multiple that approaches the platforms the public market is repricing every day.

---

The Bottom Line

Public home-based care valuations are the visible benchmark hovering over every private transaction. They will not tell you what your agency is worth — that is set by your specific financials and by competitive demand in a process — but they tell you which direction the wind is blowing and how disciplined your buyers are likely to be. Read them directionally, understand why your agency sits below them, and invest in the handful of factors that close the gap.

To translate today’s market into a real number for your agency, book a free confidential valuation call with our team.